Glenmede Investment Management’s IMAX IMAX Stock Holding History

Glenmede Investment Management’s Portfolio IMAX Stock Details IMAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-90	Closed	-$2.52K	–	1529
2025 Q2	$2.52K	Buy	+90	New	+$2.34K	﹤0.01%	1482

Other funds holding IMAX

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Glenmede Investment Management's IMAX Position: Q3 2025 in Review

Glenmede Investment Management sold out of IMAX (IMAX) in Q3 2025, closing a stake of 90 shares — an estimated $2.52K sold.

Glenmede Investment Management first reported a position in IMAX in Q2 2025 and held it in 1 quarter. The position peaked at $2.52K in Q2 2025. 209 funds tracked by Wall St. Rank hold IMAX as of Q3 2025.

Glenmede Investment Management reported no remaining IMAX position as of Q3 2025 after selling out during the quarter.
Glenmede Investment Management sold 90 IMAX shares in Q3 2025, an estimated $2.52K.
Glenmede Investment Management first reported a position in IMAX in Q2 2025 and held it in 1 quarter.
Glenmede Investment Management's IMAX position peaked at $2.52K in Q2 2025.
209 funds tracked by Wall St. Rank held IMAX as of Q3 2025.

Based on Glenmede Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.